Month: May 2017

Macrophage Pharma Appoints Development Director

Dr Joanne Bedwell-Garner joins management team Macrophage Pharma Limited (‘MPL’) the immuno-oncology development company, announced today that it has appointed Dr Joanne Bedwell-Garner as Development Director. Dr Bedwell-Garner will be responsible for advancing the clinical development of Macrophage Pharma’s lead programme, MPL-5821. This announcement follows the recent £9 million Series A financing, which was led … Continue reading “Macrophage Pharma Appoints Development Director”